The term chemsex has become central to conversations about male sexual health. Defined as the use of psychoactive substances to intensify or prolong sex, it raises medical, social and legal questions. A new call for participation in a study titled “Rapport au Sexe” asks men who have male partners to spend 20 minutes sharing their experiences. The questionnaire covers use of PrEP, condoms, routine STI screening, experiences of discrimination, stigma and sexual violence, and patterns around chemsex. Published on 16/03/2026, the appeal aims to collect diverse accounts to guide public health strategies.
Alongside the survey, care providers and community organisations are adapting. Hospitals and clinics report growing numbers of people seeking help for drug-related sexual practices and their consequences. The Geneva university hospitals (HUG) have opened a dedicated consultation to address this niche of sexual health care. This article synthesizes the research invitation, the new clinical offer in Geneva reported on 10/03/2026, and recent legal developments in France tied to the supply of substances often used in chemsex sessions. Together, these strands illustrate how prevention, treatment and law enforcement are converging around the same behaviours.
Geneva’s clinical response and how it works
The new consultation at the Hôpitaux universitaires de Geneva (HUG) is framed as a personalized, non-judgmental entry point for people affected by chemsex. Dr Matteo Reymond, from the infectious diseases and HIV unit, explains that the service begins with an intake appointment to map consumption patterns, sexual practices and expectations. That evaluation is designed to slot the person into appropriate pathways—medical care, addiction support, mental health services or community-based follow-up—rather than a one-size-fits-all programme. Importantly, the consultation is reimbursed under LAMAL, Switzerland’s mandatory health insurance, lowering financial barriers to access.
Who the service aims to reach
Health teams estimate between 1,500 and 4,000 people in the canton of Geneva could fall within the service’s target group, a figure that highlights both demand and the need for tailored responses. Community resources such as Checkpoint Genève, which has offered a specific accompaniment since 2019, act as complementary points of contact. Testimonials from clients underline the value of multiple access routes: Yvan* (42) practised chemsex for three years and required several months to stop; he credits community support and clinical options for helping him regain stability. These combined pathways are intended to reduce harm while respecting autonomy.
Risks, harm reduction and legal consequences
Medical teams stress that even if many participants describe positive experiences, the practice carries concrete hazards. Clinicians list possible outcomes including overdose, loss of control, unprotected sexual encounters, increased transmission of STIs, psychological distress and social fallout such as job loss. Harm reduction thus becomes central: offering safer-use information, access to PrEP and condoms, prompt testing, post-exposure care and a bridge to addiction services. The aim is to limit acute harms while opening doors to longer-term recovery when desired.
Legal actions linked to chemsex networks
Simultaneously, law enforcement is active where supply chains are identified. A court in Mulhouse examined trafficking related to chemsex in a trial reported on 13/03/2026: two men, identified in reporting as Jérémy (29) and Mehdi (39), were prosecuted for acquiring, possessing, transporting, consuming and selling synthetic cathinones—specifically 2-MMC and 3-MMC—during the first quarter of 2026. The investigation began after a third individual under scrutiny named a supplier, illustrating how public health concerns and criminal investigations can converge around the same networks. Such cases underline the complexity: policing supply aims to reduce harm but can also push transactions into more hidden, riskier settings.
Where harm reduction, clinical care and policy meet
Combining data from the “Rapport au Sexe” survey with clinic intake records and community feedback can help shape interventions that balance health promotion and legal oversight. Services emphasise non-stigmatising language and multiple access points so people do not avoid care for fear of prosecution or shame. For policymakers, insights from affected communities are essential to design responses that are effective and respectful of rights. If you are a man who has sex with men, the 20-minute survey cited on 16/03/2026 is an opportunity to influence how PrEP, testing, counselling and harm reduction resources are prioritised.
In short, the shifting landscape around chemsex shows the need for integrated approaches: clinical teams offering individualized care, community organisations providing practical support, and judicial systems addressing supply without undermining access to health services. Encouraging participation in research and expanding accessible, insured consultations remain practical steps that can reduce harm and improve outcomes for people who engage in these practices.